Skip to main content
. 2022 Jun 30;14(7):1393. doi: 10.3390/pharmaceutics14071393

Figure 3.

Figure 3

Scanning electron microscopy images showing the hexagonal crystalline form of TH (A) with varying sizes of particles and longitudinal amorphous structures, which confirm the formation of SLNs (B).